Affinofile Profiling: How efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV

Por Chikere, Kelechi, Chou, Tom, Gorry, Paul R., Lee, Benhur
Publicado em 2013

Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies

Por Chikere, Kelechi, Webb, Nicholas E, Chou, Tom, Borm, Katharina, Sterjovski, Jasminka, Gorry, Paul R, Lee, Benhur
Publicado no Retrovirology (2014)

Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5

Por Salimi, Hamid, Roche, Michael, Webb, Nicholas, Gray, Lachlan R., Chikere, Kelechi, Sterjovski, Jasminka, Ellett, Anne, Wesselingh, Steve L., Ramsland, Paul A., Lee, Benhur, Churchill, Melissa J., Gorry, Paul R.
Publicado em 2013

Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol

Por Liu, Su-Yang, Aliyari, Roghiyh, Chikere, Kelechi, Li, Guangming, Marsden, Matthew D., Smith, Jennifer K., Pernet, Olivier, Guo, Haitao, Nusbaum, Rebecca, Zack, Jerome A., Freiberg, Alexander N., Su, Lishan, Lee, Benhur, Cheng, Genhong
Publicado em 2012

Nipah Virus Envelope-Pseudotyped Lentiviruses Efficiently Target ephrinB2-Positive Stem Cell Populations In Vitro and Bypass the Liver Sink When Administered In Vivo

Por Palomares, Karina, Vigant, Frederic, Van Handel, Ben, Pernet, Olivier, Chikere, Kelechi, Hong, Patrick, Sherman, Sean P., Patterson, Michaela, An, Dong Sung, Lowry, William E., Mikkola, Hanna K. A., Morizono, Kouki, Pyle, April D., Lee, Benhur
Publicado em 2013

Nipah Virus Envelope-Pseudotyped Lentiviruses Efficiently Target ephrinB2-Positive Stem Cell Populations In Vitro and Bypass the Liver Sink When Administered In Vivo

Por Palomares, Karina, Vigant, Frederic, Van Handel, Ben, Pernet, Olivier, Chikere, Kelechi, Hong, Patrick, Sherman, Sean P., Patterson, Michaela, An, Dong Sung, Lowry, William E., Mikkola, Hanna K. A., Morizono, Kouki, Pyle, April D., Lee, Benhur
Publicado em 2013

Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5

Por Parker, Zahra F., Iyer, Shilpa S., Wilen, Craig B., Parrish, Nicholas F., Chikere, Kelechi C., Lee, Fang-Hua, Didigu, Chuka A., Berro, Reem, Klasse, Per Johan, Lee, Benhur, Moore, John P., Shaw, George M., Hahn, Beatrice H., Doms, Robert W.
Publicado em 2013

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations

Por Roche, Michael, Salimi, Hamid, Duncan, Renee, Wilkinson, Brendan L, Chikere, Kelechi, Moore, Miranda S, Webb, Nicholas E, Zappi, Helena, Sterjovski, Jasminka, Flynn, Jacqueline K, Ellett, Anne, Gray, Lachlan R, Lee, Benhur, Jubb, Becky, Westby, Mike, Ramsland, Paul A, Lewin, Sharon R, Payne, Richard J, Churchill, Melissa J, Gorry, Paul R
Publicado em 2013